FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Pillar Invest Corp 2. Issuer Name and Ticker or Trading Symbol IDERA PHARMACEUTICALS, INC. [ IDRA ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
PILLAR INVEST OFFSHORE SAL STARCO CTR,, BLOC B, 3RD FLOOR, OMAR DAOUK STREET
3. Date of Earliest Transaction (MM/DD/YYYY)
4/17/2020
(Street)
BEIRUT, M8 2020-3313
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) ___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  4/17/2020    J(1)    46304  D $0.00  5427697  I  By Pillar Partners Foundation, L.P. See Footnotes (1)(3)
Common Stock  4/17/2020    J(1)    103891  D $0.00  1288368  I  By Pillar Pharmaceuticals 6, L.P. See Footnotes (2)(3)
Common Stock                 21100  I  By Pillar Pharmaceuticals I, L.P. See Footnote (3)
Common Stock                 20820  I  By Pillar Pharmaceuticals II, L.P. See Footnote (3)
Common Stock                 29998  I  By Pillar Pharmaceuticals III, L.P. See Footnote (3)
Common Stock                 1000  I  By Pillar Pharmaceuticals IV, L.P. See Footnote (3)
Common Stock                 25000  I  By Pillar Pharmaceuticals V, L.P. See Footnote (3)
Common Stock                 6724  I  By Youssef El Zein See Footnote (3)
Common Stock                 190117  I  By Abude Umari See Footnotes (3)(4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  On April 17, 2020, Pillar Partners Foundation, L.P. ("Pillar Foundation") distributed in-kind, without consideration, 46,304 shares of Common Stock to Abude Umari, in accordance with his pro rata interest in Pillar Foundation. This distribution was made in accordance with the exemptions under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
(2)  On April 17, 2020, Pillar Pharmaceuticals 6, L.P. ("Pillar 6") distributed in-kind, without consideration, 103,891 shares of Common Stock to Abude Umari, in accordance with his pro rata interest in Pillar 6. This distribution was made in accordance with the exemptions under Rule 16a-9(a) and Rule 16a-13 of the Securities Exchange Act of 1934, as amended.
(3)  Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals I, L.P., Pillar Pharmaceuticals II, L.P., Pillar Pharmaceuticals III, L.P., Pillar Pharmaceuticals IV, L.P., Pillar Pharmaceuticals V, L.P., Pillar 6 and Pillar Foundation (collectively, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
(4)  Includes the shares received by Mr. Umari in the distributions reported in footnotes (1) and (2).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Pillar Invest Corp
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT, M8 2020-3313

X

Pillar Partners Foundation, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT, M8 2020-3313

X

Pillar Pharmaceuticals 6, L.P.
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT, M8 2020-3313

X

Umari Abude
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT, M8 2020-3313

X

ZEIN YOUSSEF EL
PILLAR INVEST OFFSHORE SAL STARCO CTR,
BLOC B, 3RD FLOOR, OMAR DAOUK STREET
BEIRUT, M8 2020-3313

X


Signatures
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person 9/4/2020
**Signature of Reporting Person Date
Pillar Partners Foundation, L.P., /s/ Youssef El Zein, Authorized Person 9/4/2020
**Signature of Reporting Person Date
Pillar Pharmaceuticals, 6, L.P., /s/ Youssef El Zein, Authorized Person 9/4/2020
**Signature of Reporting Person Date
/s/ Abude Umari 9/4/2020
**Signature of Reporting Person Date
/s/ Youssef El Zein 9/4/2020
**Signature of Reporting Person Date
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more Idera Pharmaceuticals Charts.
Idera Pharmaceuticals (NASDAQ:IDRA)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more Idera Pharmaceuticals Charts.